IP Library Granted Patent US 10,004,661
Granted Patent B2
US 10,004,661 · App. 15/862,110 · Granted Jun 26, 2018

System and method for titrating in vivo cellular reaction and gene expression using varying oscillation frequencies

Inventors: Robert Edward Grant (Laguna Beach, CA); Todd Mirzai (Honolulu, HI); Matthew T. Case (Laguna Hills, CA)
Assignee: STRATHSPEY CROWN HOLDINGS, LLC
A61H23/0236A61H2201/1623A61H2201/5097A61H2203/0456A61H2205/081
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,004,661
App. No.
15/862,110
Granted
Jun 26, 2018
Kind
B2
Abstract

A system and method for the present invention utilizes a generator, in combination with a radiation unit, to direct waveform energy towards a target tissue using a predetermined protocol directed by titration-like feedback. The effect of the waveform energy on cellular structures of the target tissue is periodically monitored, and the predetermined protocol is halted when the cellular structure has been transformed into a desired phenotype.

Claims (44)

1. A system for directing a waveform energy toward a target tissue to modify a phenotypic differentiation of the target tissue at a cellular level, comprising:

a waveform energy generator;

a radiation unit that is in communication with the waveform energy generator and receives a waveform energy therefrom, wherein the radiation unit is positionable relative to the target tissue;

a monitor that is configured to receive data related to the phenotypic differentiation of the target tissue; and;

a controller that is in electronic communication with the monitor and at least one of the waveform energy generator and the radiation unit,

wherein the controller comprises encoded instructions comprising both a predetermined treatment protocol and a logic operation comprising termination of the predetermined treatment protocol when data received from the monitor indicates the phenotypic differentiation of the target tissue corresponds to a desired phenotypic differentiation.

2. The system of claim 1 , wherein the waveform energy is a sonic radiation having a wavelength ranging from 20 Hz to 20 kHz.

3. The system of claim 1 , wherein the waveform energy is a sonic radiation having a wavelength of less than 20 Hz to 20 kHz.

4. The system of claim 1 , wherein the waveform energy is a sonic radiation having a wavelength of greater than 20 kHz.

5. The system of claim 1 , wherein the waveform energy is an electromagnetic energy having a wavelength of 10 −25 m to 10 3 m.

6. The system of claim 1 , wherein the monitor receives data from a stepwise titration process.

7. The system of claim 6 , wherein the stepwise titration process is selected from the group consisting of polymerase chain reaction and bioelectric impedance analysis.

8. A method of modifying a phenotypic differentiation of a target tissue at a cellular level, comprising:

identifying the target tissue and a cellular structure of the target tissue;

determining a natural frequency of the target tissue;

determining a desired phenotype of the target tissue;

providing a system comprising:

a waveform energy generator;

a radiation unit that is in communication with the waveform energy generator and receives a waveform energy therefrom, wherein the radiation unit is positionable relative to the target tissue;

a monitor that is configured to receive data related to the phenotypic differentiation of the target tissue; and;

a controller that is in electronic communication with the monitor and at least one of the waveform energy generator and the radiation unit,

wherein the controller comprises encoded instructions comprising both a predetermined treatment protocol and a logic operation comprising termination of the predetermined treatment protocol when data received from the monitor indicates the phenotypic differentiation of the target tissue corresponds to a desired phenotypic differentiation;

positioning the radiation unit to direct the waveform energy towards the target tissue;

emitting the waveform energy in accordance with the predetermined treatment protocol;

using the monitor, collecting data related to the phenotypic differentiation of the target tissue and transmitting said data to the controller; and

terminating emission of the waveform energy when the phenotypic differentiation of the target tissue correspond to the desired phenotypic differentiation.

9. The method of claim 8 , wherein the predetermined protocol comprises the steps of:

adjusting the waveform energy to a frequency f;

adjusting the amplitude of the waveform energy to an intensity level v; and

providing a time duration t d , during which the waveform energy is emitted.

10. The method of claim 9 , wherein emission of the waveform energy is continuous through time duration t d .

11. The method of claim 9 , wherein emission of the waveform energy is intermittent through time duration t d .

12. The method of claim 9 , wherein adjustment of the frequency f is accomplished by alternating between a first frequency f 1 and a second frequency f 2 , wherein f 1 and f 2 are different frequencies.

13. The method of claim 12 , wherein alternation between f 1 and f 2 is performed at a predetermined repetition rate.

14. The method of claim 9 , wherein emission of the waveform energy is provided as a plurality of waveform energy pulses, wherein each one of the plurality of waveform energy pulses has a time duration t d and is separate from an adjacent one of the plurality of waveform energy pulses by a predetermined time interval t i , and wherein t i is greater than t d .

15. The method of claim 9 , further comprising the steps of:

positioning the radiation unit at a distance d from the target tissue; wherein d is greater than 10 mm; and

using the radiation unit, focusing the waveform energy on the target tissue.

16. The method of claim 9 , wherein the waveform energy is a sonic radiation having a wavelength ranging from 20 Hz to 20 kHz.

17. The method of claim 9 , wherein the waveform energy is a sonic radiation having a wavelength of less than 20 Hz to 20 kHz.

18. The method of claim 9 , wherein the waveform energy is a sonic radiation having a wavelength of greater than 20 kHz.

19. The method of claim 9 , wherein the waveform energy is an electromagnetic energy having a wavelength of 10 −25 m to 10 3 m.

20. The method of claim 9 , wherein the monitor receives data from a stepwise titration process.

21. The method of claim 9 , wherein the stepwise titration process is selected from the group consisting of polymerase chain reaction and bioelectric impedance analysis.

Assignments (2)
CHANGE OF NAME Recorded Apr 25, 2023
From: STRATHSPEY CROWN, LLC
To: CROWN HOLDINGS, LLC
Reel/Frame 063439/0244 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 22, 2018
From: GRANT, ROBERT EDWARD; MIRZAI, TODD; CASE, MATTHEW T.
To: STRATHSPEY CROWN HOLDINGS, LLC
Reel/Frame 045311/0542 →
Continuity (3)
Continuation 14738518 · Jun 12, 2015
Continuation In Part 14488101 · Sep 16, 2014
Related Publication 20180125747A1 · May 10, 2018